Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P W Armstrong

Showing results (241-250 of 281) with videos related to

Pageof 29
Sort By:
American Heart Journal|August 30, 2003
Collaborative Angiographic Patency Trial Of Recombinant Staphylokinase (CAPTORS II)P W Armstrong, J Burton, S Pakola, et al.
The New England Journal of Medicine|August 31, 1995
Regional variation across the United States in the management of acute myocardial infarction. GUSTO-1 Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary ArteriesL Pilote, R M Califf, S Sapp, et al.
The New England Journal of Medicine|May 25, 1995
Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarctionD B Mark, M A Hlatky, R M Califf, et al.
Circulation|September 12, 2001
Early reinfarction after fibrinolysis: experience from the global utilization of streptokinase and tissue plasminogen activator (alteplase) for occluded coronary arteries (GUSTO I) and global use of strategies to open occluded coronary arteries (GUSTO III) trialsM P Hudson, C B Granger, E J Topol, et al.
Circulation|September 15, 1996
One-year results from the Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries (GUSTO-I) trial. GUSTO-I InvestigatorsR M Califf, H D White, F Van de Werf, et al.
The Canadian Journal of Cardiology|November 7, 2000
Temporal evolution in the management of acute ST elevation myocardial infarction: the seven-year GUSTO experience from canada and the united states. The North American GUSTO-I and GUSTO-III investigatorsW C Chang, Y Fu, E M Ohman, et al.
Heart (British Cardiac Society)|May 19, 2009
Benefit of angiographic spontaneous reperfusion in STEMI: does it extend to diabetic patients?K R Bainey, Y Fu, C B Granger, et al.
JAMA|May 24, 1995
Variations in patient management and outcomes for acute myocardial infarction in the United States and other countries. Results from the GUSTO trial. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary ArteriesF Van de Werf, E J Topol, K L Lee, et al.
JAMA|September 28, 1994
Comparison of the appropriateness of coronary angiography and coronary artery bypass graft surgery between Canada and New York StateE A McGlynn, C D Naylor, G M Anderson, et al.
European Heart Journal|October 18, 2003
Risk of intracranial haemorrhage with combined fibrinolytic and glycoprotein IIb/IIIa inhibitor therapy in acute myocardial infarction. Dichotomous response as a function of age in the GUSTO V trialS Savonitto, P W Armstrong, A M Lincoff, et al.
Pageof 29

Showing results (241-250 of 281) with videos related to

Sort By:
Pageof 29
American Heart Journal|August 30, 2003
Collaborative Angiographic Patency Trial Of Recombinant Staphylokinase (CAPTORS II)P W Armstrong, J Burton, S Pakola, et al.
The New England Journal of Medicine|August 31, 1995
Regional variation across the United States in the management of acute myocardial infarction. GUSTO-1 Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary ArteriesL Pilote, R M Califf, S Sapp, et al.
The New England Journal of Medicine|May 25, 1995
Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarctionD B Mark, M A Hlatky, R M Califf, et al.
Circulation|September 12, 2001
Early reinfarction after fibrinolysis: experience from the global utilization of streptokinase and tissue plasminogen activator (alteplase) for occluded coronary arteries (GUSTO I) and global use of strategies to open occluded coronary arteries (GUSTO III) trialsM P Hudson, C B Granger, E J Topol, et al.
Circulation|September 15, 1996
One-year results from the Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries (GUSTO-I) trial. GUSTO-I InvestigatorsR M Califf, H D White, F Van de Werf, et al.
The Canadian Journal of Cardiology|November 7, 2000
Temporal evolution in the management of acute ST elevation myocardial infarction: the seven-year GUSTO experience from canada and the united states. The North American GUSTO-I and GUSTO-III investigatorsW C Chang, Y Fu, E M Ohman, et al.
Heart (British Cardiac Society)|May 19, 2009
Benefit of angiographic spontaneous reperfusion in STEMI: does it extend to diabetic patients?K R Bainey, Y Fu, C B Granger, et al.
JAMA|May 24, 1995
Variations in patient management and outcomes for acute myocardial infarction in the United States and other countries. Results from the GUSTO trial. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary ArteriesF Van de Werf, E J Topol, K L Lee, et al.
JAMA|September 28, 1994
Comparison of the appropriateness of coronary angiography and coronary artery bypass graft surgery between Canada and New York StateE A McGlynn, C D Naylor, G M Anderson, et al.
European Heart Journal|October 18, 2003
Risk of intracranial haemorrhage with combined fibrinolytic and glycoprotein IIb/IIIa inhibitor therapy in acute myocardial infarction. Dichotomous response as a function of age in the GUSTO V trialS Savonitto, P W Armstrong, A M Lincoff, et al.
Pageof 29